Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Eaton Named to 100 Best Corporate Citizens List for 15th Consecutive Year by 3BL Media
Eaton Named to 100 Best Corporate Citizens List for 15th Consecutive Year by 3BL Media


Power management company Eaton (NYSE:ETN) today announced that it has been named one of the 100 Best Corporate Citizens for the 15th consecutive year by 3BL Media. The ranking recognizes

EQS-News: Mobile TeleSystems PJSC: MTS Announces Q1 2022 Results
EQS-News: Mobile TeleSystems PJSC: MTS Announces Q1 2022 Results
EQS-News: Mobile TeleSystems PJSC: MTS Announces Q1 2022 Results
PAO Severstal: Severstal obtains permission to maintain its GDR program
PAO Severstal: Severstal obtains permission to maintain its GDR program
PAO Severstal: Severstal obtains permission to maintain its GDR program
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
The Vanguard Group, Inc.: GXO Logistics, Inc.
The Vanguard Group, Inc.: GXO Logistics, Inc.
The Vanguard Group, Inc.: GXO Logistics, Inc.
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
DGAP-News: PNE AG: Annual General Meeting approves dividend
DGAP-News: PNE AG: Annual General Meeting approves dividend
DGAP-News: PNE AG: Annual General Meeting approves dividend
Fuller, Smith & Turner PLC: HOL-Holding(s) in Company
Fuller, Smith & Turner PLC: HOL-Holding(s) in Company
Fuller, Smith & Turner PLC: HOL-Holding(s) in Company
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Additional details regarding second interim dividend
Additional details regarding second interim dividend
Additional details regarding second interim dividend
SThree: DSH-Director/PDMR Shareholding*
SThree: DSH-Director/PDMR Shareholding*
SThree: DSH-Director/PDMR Shareholding*
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
REPLY – Digital Experience Is Recognised as No. 1 Internet Agency and Company Group for the Fourth Year in a Row by BVDW
REPLY – Digital Experience Is Recognised as No. 1 Internet Agency and Company Group for the Fourth Year in a Row by BVDW


As done in the previous three years, the Bundesverband Digitale Wirtschaft (BVDW) honours Reply – Digital Experience once again as the top company in their ranking of Internet Agencies for 2022.

EQS-News: PJSC Mechel : MECHEL REPORTS RECEIVING PERMISSION TO CONTINUE CIRCULATION OF ITS ADRS OUTSIDE RUSSIA
EQS-News: PJSC Mechel : MECHEL REPORTS RECEIVING PERMISSION TO CONTINUE CIRCULATION OF ITS ADRS OUTSIDE RUSSIA
EQS-News: PJSC Mechel : MECHEL REPORTS RECEIVING PERMISSION TO CONTINUE CIRCULATION OF ITS ADRS OUTSIDE RUSSIA
Sberbank: Sber informs on the conversion of depository receipts into ordinary shares
Sberbank: Sber informs on the conversion of depository receipts into ordinary shares
Sberbank: Sber informs on the conversion of depository receipts into ordinary shares
Lysogene Provides Clinical Update on AAVance Phase 2/3 Clinical Trial with Gene Therapy LYS-SAF302 for the Treatment of MPS IIIA at the 25th Annual ASGCT Meeting
Lysogene Provides Clinical Update on AAVance Phase 2/3 Clinical Trial with Gene Therapy LYS-SAF302 for the Treatment of MPS IIIA at the 25th Annual ASGCT Meeting


Regulatory News:



Lysogene (FR0013233475 – LYS), a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, provided updated clinical data from the ongoing AAVance

DGAP-News: wallstreet:online AG plans renaming - Smartbroker’s significance to be reflected in the company’s name
DGAP-News: wallstreet:online AG plans renaming - Smartbroker’s significance to be reflected in the company’s name
DGAP-News: wallstreet:online AG plans renaming - Smartbroker’s significance to be reflected in the company’s name
DGAP-Adhoc: Siemens Energy AG: Siemens Energy comments on media reports
DGAP-Adhoc: Siemens Energy AG: Siemens Energy comments on media reports
DGAP-Adhoc: Siemens Energy AG: Siemens Energy comments on media reports
DGAP-News: Formycon Publishes Annual Financial Statements for the 2021 Financial Year
DGAP-News: Formycon Publishes Annual Financial Statements for the 2021 Financial Year
DGAP-News: Formycon Publishes Annual Financial Statements for the 2021 Financial Year
DGAP-News: Exasol publishes audited consolidated financial statements 2021 and results for Q1 2022
DGAP-News: Exasol publishes audited consolidated financial statements 2021 and results for Q1 2022
DGAP-News: Exasol publishes audited consolidated financial statements 2021 and results for Q1 2022
DGAP-News: Energiekontor AG: Wind farm project Vettweiss-Müddersheim sold to Danish investor
DGAP-News: Energiekontor AG: Wind farm project Vettweiss-Müddersheim sold to Danish investor
DGAP-News: Energiekontor AG: Wind farm project Vettweiss-Müddersheim sold to Danish investor
DGAP-News: Deutsche Familienversicherung reaches profit zone with 37% growth
DGAP-News: Deutsche Familienversicherung reaches profit zone with 37% growth
DGAP-News: Deutsche Familienversicherung reaches profit zone with 37% growth
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
DGAP-News: DEFENCE’S NOVEL ACCUVAC-PTE7 VACCINE SHOWS COMPLETE PROTECTION FROM CERVICAL CANCER
DGAP-News: DEFENCE’S NOVEL ACCUVAC-PTE7 VACCINE SHOWS COMPLETE PROTECTION FROM CERVICAL CANCER
DGAP-News: DEFENCE’S NOVEL ACCUVAC-PTE7 VACCINE SHOWS COMPLETE PROTECTION FROM CERVICAL CANCER